Once Daily Sublingual Immunotherapy without Updosing – A New Treatment Schedule
- 1 July 2006
- journal article
- research article
- Published by S. Karger AG in International Archives of Allergy and Immunology
- Vol. 140 (4), 321-326
- https://doi.org/10.1159/000093710
Abstract
Background: Treatment regimens with specific immunotherapy include updosing. Due to excellent tolerance of sublingual immunotherapy (SLIT), it was hypothesized that administration of once-daily SLIT could be initiated safely without updosing. The objective was to evaluate tolerability of SLIT administered once daily without updosing. Methods: 135 patients suffering from allergic rhinitis with/without asthma were included in a double-blind, placebo-controlled, parallel-group study. Patients were randomized into two groups. Group 1 (n = 69) received active treatment throughout the study, including 10 days updosing (T1), 20 days maintenance treatment (T2), and 2 consecutive months on maintenance treatment (T3 and T4). Group 2 (n = 66) obtained placebo updosing (T1), placebo maintenance (T2), initiated active treatment (maintenance) at T3, and continued active treatment until the end of the study (T4). Adverse events (AEs) were assessed at T1–T4. 66 grass- and 69 mite-allergic patients were evenly distributed between groups. Results: 229 AEs were reported, 157 AEs were related to treatment. The most frequently reported AEs (>5% of patients in any group) related to treatment were oral itching, ocular itching, rhinitis, and sublingual edema. For group 1 at T2, the rate of all AEs related to treatment per dose administered was 1.79%, and for group 2 at T3 the rate was 1.33% (p = 0.37). For the most frequently reported AE, oral itching, the rate per dose administered was 1.01% for group 1 at T2, and 0.74% for group 2 at T3 (p = 0.53). Conclusions: Once daily SLIT was well tolerated and can be safely initiated without updosing.Keywords
This publication has 7 references indexed in Scilit:
- Adherence to MedicationThe New England Journal of Medicine, 2005
- Sublingual immunotherapy for allergic rhinitis: systematic review and meta‐analysis*Allergy, 2004
- Current concepts and therapeutic strategies forallergic rhinitis in school-age childrenClinical Therapeutics, 2004
- Noninjection routes for immunotherapyJournal of Allergy and Clinical Immunology, 2003
- Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites:a double-blind, placebo-controlled studyAllergy, 2000
- Post‐marketing surveillance study on the safety of sublingual immunotherapy in pediatric patientsAllergy, 1999
- Sublingual versus injective immunotherapy in grass pollen allergic patients: a double blind (double dummy) studyClinical & Experimental Allergy, 1996